Remote ischaemic conditioning for efficacy in patients with aneurysmal subarachnoid haemorrhage (REPAIR): protocol for a multicentre, randomised, double-blind, sham-controlled, parallel-group trial
机构:[1]Beijing Neurosurgical Institute, Beijing Tiantan Hospital, Capital Medical University, Beijing, China首都医科大学附属天坛医院[2]Beijing Institute For Brain Disorders, Beijing, China[3]Department of Neurology, Xuanwu Hospital, Capital Medical University, Beijing, China神经科系统神经内科首都医科大学宣武医院[4]Zhujiang Hospital, Guangzhou, Guangdong, China南方医科大学珠江医院[5]Department of Neurology, Medical College of Georgia, Augusta, Georgia, USA
Beijing Municipal Administration of
Hospitals’ Ascent Plan (DFL20190501), BTH Coordinated Development—Beijing
Science and Technology Planning Project (Z181100009618035), Research and
Promotion Program of Appropriate Techniques for Intervention of Chinese High-risk
Stroke People (GN-2020R0007), Beijing Natural Science Foundation (19L2013,
22G10396), National Natural Science Foundation of China (81771233, 82171290).
语种:
外文
PubmedID:
中科院(CAS)分区:
出版当年[2025]版:
大类|4 区医学
小类|4 区医学:内科
最新[2025]版:
大类|4 区医学
小类|4 区医学:内科
第一作者:
第一作者机构:[1]Beijing Neurosurgical Institute, Beijing Tiantan Hospital, Capital Medical University, Beijing, China
共同第一作者:
通讯作者:
推荐引用方式(GB/T 7714):
Jin Tonghu,Niu Hao,Liu Lan,et al.Remote ischaemic conditioning for efficacy in patients with aneurysmal subarachnoid haemorrhage (REPAIR): protocol for a multicentre, randomised, double-blind, sham-controlled, parallel-group trial[J].BMJ Open.2025,15(8):e101350.doi:10.1136/bmjopen-2025-101350.
APA:
Jin Tonghu,Niu Hao,Liu Lan,Yin Yunjian,Zhao Wenbo...&Ji Xunming.(2025).Remote ischaemic conditioning for efficacy in patients with aneurysmal subarachnoid haemorrhage (REPAIR): protocol for a multicentre, randomised, double-blind, sham-controlled, parallel-group trial.BMJ Open,15,(8)
MLA:
Jin Tonghu,et al."Remote ischaemic conditioning for efficacy in patients with aneurysmal subarachnoid haemorrhage (REPAIR): protocol for a multicentre, randomised, double-blind, sham-controlled, parallel-group trial".BMJ Open 15..8(2025):e101350